CaRi-Heart

Trends

• FDA authorizations extend clinical AI into new specialties and LLMs

Items

1. Jul 29

   FDA authorizes Caristo's CaRi-Heart

   A De Novo authorization makes CaRi-Heart the first US-authorized technology to quantify coronary inflammation from routine coronary CT angiography, producing a fat-attenuation-index biomarker and a 10-year cardiac-risk score.